CHST13 antibody (AA 151-250) (HRP)
Quick Overview for CHST13 antibody (AA 151-250) (HRP) (ABIN5675510)
Target
See all CHST13 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 151-250
-
Cross-Reactivity
- Mouse
-
Predicted Reactivity
- Human,Rat,Dog
-
Purification
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human CHST13
-
Isotype
- IgG
-
-
-
-
Application Notes
-
WB 1:300-5000
IHC-P 1:200-400
IHC-F 1:100-500 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Expiry Date
- 12 months
-
-
- CHST13 (Carbohydrate (Chondroitin 4) Sulfotransferase 13 (CHST13))
-
Alternative Name
- CHST13
-
Background
-
Synonyms: Carbohydrate sulfotransferase 13, CHST13, Chondroitin 4-O-sulfotransferase 3, Chondroitin 4-sulfotransferase 3, C4ST-3, C4ST3
Background: Catalyzes the transfer of sulfate to position 4 of the N-acetylgalactosamine (GalNAc) residue of chondroitin. Chondroitin sulfate constitutes the predominant proteoglycan present in cartilage and is distributed on the surfaces of many cells and extracellular matrices. Transfers sulfate to the C4 hydroxyl of beta1,4-linked GalNAc that is substituted with a beta-linked glucuronic acid at the C-3 hydroxyl. No activity toward dermatan.
-
Gene ID
- 166012
-
UniProt
- Q8NET6
-
Pathways
- Glycosaminoglycan Metabolic Process
Target
-